HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukitaka Ideyama Selected Research

YM-359445

3/2006YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukitaka Ideyama Research Topics

Disease

5Neoplasms (Cancer)
07/2006 - 05/2002
2Carcinogenesis
01/2006 - 05/2002
1Melanoma (Melanoma, Malignant)
07/2006
1Pathologic Neovascularization
03/2006
1Lung Neoplasms (Lung Cancer)
03/2006
1Prostatic Neoplasms (Prostate Cancer)
01/2006
1Prostatic Intraepithelial Neoplasia
01/2006
1Body Weight (Weight, Body)
11/2005
1Hyperplasia
05/2002
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2002

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2006 - 11/2005
2Paclitaxel (Taxol)FDA LinkGeneric
03/2006 - 11/2005
1YM-201627IBA
07/2006
1Growth InhibitorsIBA
07/2006
1matrigelIBA
07/2006
1Tyrosine Kinase InhibitorsIBA
03/2006
1Cytotoxins (Cytolysins)IBA
03/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2006
1vandetanib (ZD6474)IBA
03/2006
13- (4- bromo- 2,6- difluorobenzyloxy)- 5- (3- (4- pyrrolidin- 1- ylbutyl)ureido)isothiazole- 4- carboxylic acid amideIBA
03/2006
1cediranib (AZD2171)IBA
03/2006
1ErbB Receptors (EGF Receptor)IBA
03/2006
1YM-359445IBA
03/2006
1Gefitinib (Iressa)FDA Link
03/2006
1Sunitinib (Sutent)FDA Link
03/2006
1bicalutamide (Casodex)FDA LinkGeneric
01/2006
1Androgen Antagonists (Antiandrogens)IBA
01/2006
1YM-231146IBA
11/2005
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2002
1Tumor Biomarkers (Tumor Markers)IBA
05/2002
1ButylhydroxybutylnitrosamineIBA
05/2002

Therapy/Procedure

1Oral Administration
03/2006
1Chemoprevention
01/2006
1Drug Therapy (Chemotherapy)
11/2005
1Therapeutics
11/2005